Clinical Trial Update: Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on modafinil for cognitive dysfunction in schizophrenia and schizoaffective disorder; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Modafinil (modafinil)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-09-29